Lieberson Robert E, Eckermann Jan, Meyer William, Trang Tung
Department of Neurosurgery and Kern NeuroScience Institute, Kern Medical Center.
Department of Otolaryngology, Kern Medical Center.
Cureus. 2017 Feb 3;9(2):e1009. doi: 10.7759/cureus.1009.
FlowSafe (BeckerSmith Medical, Irvine, CA, USA) is a novel, robotic, external lumbar drainage (ELD) system, which was designed to control cerebrospinal fluid (CSF) drainage, reduce complications, and decrease treatment costs.
Forty-seven consecutive neurosurgical patients requiring ELD were treated using the FlowSafe system.
In 39 of 40 patients with traumatic and surgical dural openings, potential CSF leaks were avoided. In seven patients with suspected normal pressure hydrocephalus, post-infectious ventriculomegaly, or pseudotumor cerebrum, we were able to assess the likelihood of improvement with shunting. The system, therefore, produced what we considered to be the "desired result" in 46 of 47 patients (98%). Our one treatment failure (2%) involved a patient with unrecognized hydrocephalus who, following a Chiari repair with a dural patch graft, was drained for six days. A persistent CSF leak eventually required a reoperation. Two patients (4%) described low-pressure headaches during treatment. Both responded to temporarily suspending or reducing the drainage rate. We saw no complications. Required nursing interventions were minimal. Conclusions: The FlowSafe system was safe and effective. In our experience, there were fewer complications compared to currently available ELD systems. The FlowSafe was well tolerated by our patients. The near elimination of nursing interventions should allow lumbar drainage to be delivered in less costly, non-intensive care unit settings. Larger trials will be needed.
FlowSafe(美国加利福尼亚州欧文市的BeckerSmith Medical公司)是一种新型的机器人辅助外部腰椎引流(ELD)系统,其设计目的是控制脑脊液(CSF)引流、减少并发症并降低治疗成本。
连续47例需要进行ELD的神经外科患者使用FlowSafe系统进行治疗。
在40例有创伤性和手术性硬脑膜开口的患者中,39例避免了潜在的脑脊液漏。在7例疑似正常压力脑积水、感染后脑室扩大或假性脑瘤的患者中,我们能够评估分流改善的可能性。因此,该系统在47例患者中的46例(98%)产生了我们认为的“理想结果”。我们的一例治疗失败(2%)涉及一名未被识别的脑积水患者,该患者在进行Chiari修复并使用硬脑膜补片移植后,引流了6天。持续的脑脊液漏最终需要再次手术。两名患者(4%)在治疗期间描述有低压性头痛。两者均通过暂时暂停或降低引流速率得到缓解。我们未观察到并发症。所需的护理干预极少。结论:FlowSafe系统安全有效。根据我们的经验,与目前可用的ELD系统相比,并发症更少。我们的患者对FlowSafe耐受性良好。几乎无需护理干预应能使腰椎引流在成本更低的非重症监护病房环境中进行。需要进行更大规模的试验。